Indeed, in RA patients responding to TNFα inhibitors, hypoxia levels in synovial tissue were found to be reduced, leading to a reduction in the hypoxic microenvironment, mitochondrial DNA mutations and a significant reduction in disease activity. Here, TNF is linked to rheumatoid arthritis.